Dutch Start-Up Dezima Pharma In-Licenses First Pipeline Drug from Mitsubishi Tanabe
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 1 (Table of Contents)
Published: 28 Jan-2013
DOI: 10.3833/pdr.v2013.i1.1877 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Dutch start-up Dezima Pharma has in-licensed the cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS